Validity and utility of the ADAS-L for measurement of cognitive and functional impairment in geriatric schizophrenic inpatients.

Autor: Kincaid MM; Mount Sinai School of Medicine, New York, NY 10029, USA., Harvey PD, Parrella M, White L, Putnam KM, Powchik P, Davidson M, Mohs RC
Jazyk: angličtina
Zdroj: The Journal of neuropsychiatry and clinical neurosciences [J Neuropsychiatry Clin Neurosci] 1995 Winter; Vol. 7 (1), pp. 76-81.
DOI: 10.1176/jnp.7.1.76
Abstrakt: This study examined the usefulness of the Alzheimer's Disease Assessment Scale-Late Version (ADAS-L) for assessing cognitive and behavioral impairment in geriatric schizophrenic patients. Subjects were 339 geriatric schizophrenic inpatients. Discriminant function analyses compared the Mini-Mental State Examination (MMSE) with the ADAS-L as independent variables predicting the level of impairment on the criterion measure, the Clinical Dementia Rating. The ADAS-L surpassed the MMSE at correctly distinguishing severe to profound impairment; the MMSE was superior for identifying absent or questionable impairment. Findings provide evidence for the concurrent validity of the ADAS-L as an instrument for measuring impairment in geriatric schizophrenic inpatients.
Databáze: MEDLINE